Collection 16 January 2024

Editors Choice 2023

The Editor of Prostate Cancer and Prostatic Diseases is delighted to share with you this Editor's Choice collection featuring some of the best research and reviews published in the journal in 2023. These papers showcase the breadth of scope and coverage that this journal consistently delivers to its readers.

Content

Best of 2023 in Prostate Cancer and Prostatic Diseases
- Cosimo De Nunzio
- Riccardo Lombardo
Editorial23 Jan 2024 Prostate Cancer and Prostatic Diseases
The impact of race on survival in metastatic prostate cancer: a systematic literature review
- Stephen J. Freedland
- Imtiaz A. Samjoo
- Bhakti Arondekar
Review ArticleOpen Access17 Aug 2023 Prostate Cancer and Prostatic Diseases
Role of targeted biopsy, perilesional biopsy, random biopsy, and their combination in the detection of clinically significant prostate cancer by mpMRI/transrectal ultrasonography fusion biopsy in confirmatory biopsy during active surveillance program
- Giacomo Novara
- Fabio Zattoni
- Fabrizio Dal Moro
Article12 Oct 2023 Prostate Cancer and Prostatic Diseases
The transition from transrectal to transperineal prostate biopsy without antibiotic prophylaxis: Cancer detection rates and complication rates
- Renée Hogenhout
- Sebastiaan Remmers
- Monique J. Roobol
Article11 Jan 2023 Prostate Cancer and Prostatic Diseases
Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs)
- Rossella Nicoletti
- Andrea Alberti
- Jeremy Yuen Chun Teoh
Review Article25 Jul 2023 Prostate Cancer and Prostatic Diseases
15-year biochemical failure, metastasis, salvage therapy, and cancer-specific and overall survival rates in men treated with robotic radical prostatectomy for PSA-screen detected prostate cancer
- Akshay Sood
- Ralph Grauer
- Mani Menon
Article4 May 2023 Prostate Cancer and Prostatic Diseases
Genomic classifiers and prognosis of localized prostate cancer: a systematic review
- Matthew J. Boyer
- David J. Carpenter
- Karen M. Goldstein
Article10 Jan 2024 Prostate Cancer and Prostatic Diseases
Impact of persistent PSA after salvage radical prostatectomy: a multicenter study
- Felix Preisser
- Reha-Baris Incesu
- Derya Tilki
ArticleOpen Access6 Oct 2023 Prostate Cancer and Prostatic Diseases
Application of next-generation imaging in biochemically recurrent prostate cancer
- Judd W. Moul
- Neal D. Shore
- Stephen J. Freedland
Review ArticleOpen Access7 Sep 2023 Prostate Cancer and Prostatic Diseases
Primary bladder neck obstruction in men—new perspectives in physiopathology
- Hannes Cash
- Johann Jakob Wendler
- Luca Cindolo
PerspectiveOpen Access8 Jul 2023 Prostate Cancer and Prostatic Diseases
Real-world four-year functional and surgical outcomes of Rezum therapy in younger versus elderly men
- Michael Zhu
- Mustufa Babar
- Michael Ciatto
Article24 Aug 2023 Prostate Cancer and Prostatic Diseases
Quality of information and appropriateness of ChatGPT outputs for urology patients
- Andrea Cocci
- Marta Pezzoli
- Emil Durukan
Article29 Jul 2023 Prostate Cancer and Prostatic Diseases
Effect of omega-3 fatty acid diet on prostate cancer progression and cholesterol efflux in tumor-associated macrophages—dependence on GPR120
- Pei Liang
- Susanne M. Henning
- William J. Aronson
ArticleOpen Access23 Oct 2023 Prostate Cancer and Prostatic Diseases

Editors Choice 2023

Content

Best of 2023 in Prostate Cancer and Prostatic Diseases

The impact of race on survival in metastatic prostate cancer: a systematic literature review

Role of targeted biopsy, perilesional biopsy, random biopsy, and their combination in the detection of clinically significant prostate cancer by mpMRI/transrectal ultrasonography fusion biopsy in confirmatory biopsy during active surveillance program

The transition from transrectal to transperineal prostate biopsy without antibiotic prophylaxis: Cancer detection rates and complication rates

Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs)

15-year biochemical failure, metastasis, salvage therapy, and cancer-specific and overall survival rates in men treated with robotic radical prostatectomy for PSA-screen detected prostate cancer

Genomic classifiers and prognosis of localized prostate cancer: a systematic review

Impact of persistent PSA after salvage radical prostatectomy: a multicenter study

Application of next-generation imaging in biochemically recurrent prostate cancer

Primary bladder neck obstruction in men—new perspectives in physiopathology

Real-world four-year functional and surgical outcomes of Rezum therapy in younger versus elderly men

Quality of information and appropriateness of ChatGPT outputs for urology patients

Effect of omega-3 fatty acid diet on prostate cancer progression and cholesterol efflux in tumor-associated macrophages—dependence on GPR120

Search

Quick links